Pancreatic cancer
Results
Phase 2
This trial looked at an immunotherapy drug called IMM-101 with gemcitabine chemotherapy for advanced pancreatic cancer.
Recruitment start: 1 July 2011
Recruitment end: 21 August 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Angus Dalgleish
Experimental Cancer Medicine Centre (ECMC)
Immodulon Therapeutics Ltd
Last reviewed: 06 Mar 2018
CRUK internal database number: 9321
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
